» Articles » PMID: 37097586

Incidence and Clinical Characteristic of Ocular Surface Manifestation: an Evaluation of Conjunctival Swab Results in Corona Virus 2019 (COVID-19) Patients in Jakarta, Indonesia

Abstract

Objectives: This study aimed to investigate the spectrum of ocular characteristics and viral presence in the conjunctival swab of patients with COVID-19.

Methods: In this cross-sectional study, fifty-three patients were recruited from two COVID-19 referral hospitals in Jakarta (Cipto Mangunkusumo Hospital and Persahabatan Hospital) from July 2020 to March 2021. The inclusion criteria were patients who were suspected of or confirmed cases of COVID-19 with or without ocular symptoms. Demographic data, history of COVID-19 exposure, underlying medical condition, systemic symptoms, ocular symptoms, supporting laboratory results, reverse-transcriptase polymerase chain reaction (RT-PCR) of naso-oropharyngeal (NOP) swab and conjunctival swab were collected.

Results: Fifty-three patients who were suspected, probable or confirmed cases of Covid-19 were included. Forty-six out of 53 patients (86.79%) tested positive for either Covid-19 antibody rapid test or naso-oropharyngeal (NOP) swab. Forty-two patients tested positive for NOP swab. Fourteen out of 42 patients (33.33%) experienced symptoms of ocular infection including red eye, epiphora, itchy eyes, and eye discharge. None of these patients were tested positive for conjunctival swab. Two out of 42 patients (4.76%), who were tested positive for conjunctival swab, did not experience any ocular symptoms.

Conclusions: Establishing the relationship between Covid-19 infection, ocular symptoms, and presence of SARS-CoV-2 virus on the ocular surface proves to be challenging. In Covid-19 patients, ocular symptoms did not warrant a positive conjunctival swab result. On the contrary, a patient without ocular symptoms can also have detectable presence of SARS-CoV-2 virus on the ocular surface.

Citing Articles

Exploring the Ocular Transmission Potential of Severe Acute Respiratory Syndrome Coronavirus 2 and the Assessment of Conjunctival Swab Test Results: A Concise Review.

Mirzaei A, Djalilian A, Baharnoori S, Bohrani Sefidan B, Shahriari M, Cheraqpour K J Curr Ophthalmol. 2025; 36(2):122-128.

PMID: 40012799 PMC: 11856114. DOI: 10.4103/joco.joco_35_24.


Considerations of COVID-19 in Ophthalmology.

Salvetat M, Musa M, Pellegrini F, Salati C, Spadea L, Zeppieri M Microorganisms. 2023; 11(9).

PMID: 37764064 PMC: 10538084. DOI: 10.3390/microorganisms11092220.

References
1.
Santoro D, Sousa L, Camara N, de Freitas D, Oliveira L . SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease. Front Physiol. 2021; 12:612319. PMC: 7907452. DOI: 10.3389/fphys.2021.612319. View

2.
Sonmez A, Aydin Kurna S, Aslan F, Kaplan F, Acikalin B, Eker P . SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods. Int Ophthalmol. 2022; 42(8):2425-2438. PMC: 8855749. DOI: 10.1007/s10792-022-02243-3. View

3.
Xia J, Tong J, Liu M, Shen Y, Guo D . Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; 92(6):589-594. PMC: 7228294. DOI: 10.1002/jmv.25725. View

4.
Karabela Y, Karabela S, Ozbas M, Kasikci H, Yasar K . Investigation of SARS-CoV-2 in tear and conjunctival secretions of hospitalized patients with clinically-confirmed COVID-19 pneumonia. BMC Infect Dis. 2021; 21(1):918. PMC: 8419816. DOI: 10.1186/s12879-021-06630-6. View

5.
Deng W, Bao L, Gao H, Xiang Z, Qu Y, Song Z . Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun. 2020; 11(1):4400. PMC: 7467924. DOI: 10.1038/s41467-020-18149-6. View